Immediate Impact

13 standout
Sub-graph 1 of 7

Citing Papers

Patient‐derived xenograft model in cancer: establishment and applications
2025 Standout
Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
2 intermediate papers

Works of Sandra Lejniece being referenced

High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients - final analysis of a randomized, multicenter, phase III trial
2012
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study
2010

Author Peers

Author Last Decade Papers Cites
Sandra Lejniece 102 54 19 48 29 185
Tuğrul Elverdi 70 61 36 47 38 154
Émilie Chalayer 105 55 16 27 29 229
Yulia Volchek 196 93 50 79 29 272
Eun‐Jung Jang 126 105 17 18 26 196
Nahoko Hatsumi 219 58 22 49 28 290
Yali Zhou 65 69 14 15 29 253
Masaaki� Hotta 125 48 41 62 40 266
Sylvia Aidé Martínez‐Cabriales 50 15 49 23 26 258
Tamara Belotti 46 16 21 28 16 149
G Marinone 66 38 13 24 34 148

All Works

Loading papers...

Rankless by CCL
2026